Trademark Overview
On Wednesday, November 13, 2024, a trademark application was filed for SYNCOOP with the United States Patent and Trademark Office. The USPTO has given the SYNCOOP trademark a serial number of 98851304. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, November 13, 2024. This trademark is owned by MERCK KGAA. The SYNCOOP trademark is filed in the Communication Services, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, Personal, and Legal & Social Services categories with the following description:
Electronic databases in the fields of drug development and drug manufacturing, recorded on computer media; bioinformatics software for storing, indexing, searching, retrieving, and accessing information about biological data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug discovery, drug development, and drug manufacturing; chemoinformatics software for storing, indexing, searching, retrieving, and accessing information about chemical compounds and chemical data for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; software for use in biological and chemical modelling, analysis and information management for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility o...
Providing access to databases for use in retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
Licensing of computer software used for retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery, drug development, and drug manufacturing; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
Biotechnology and pharmaceutical research relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, and drug development; professional consultancy in relation to drug development; scientific research and development for others; scientific research in the nature of analysis and preparation of data relating to retrosynthesis, optimization of organic chemistry reactions and synthesis, assessing synthetic accessibility of real and virtual molecules, drug discovery and drug development; provision of information in relation to drug discovery and drug development; provision of scientific information related to pharmacy; none of the foregoing for use in connection with synthetic patients, simulated patients, synthetic electronic patient healthcare records, synthetic patient data and associated healthcare records, nor in the field of medical science and medical consultancy
